Patrick Vink


Patrick Vink is a seasoned professional with more than 30 years of experience from senior roles at leading pharmaceutical and biotechnology companies. With a proven track record of building and growing businesses through positions spanning operations, sales, and marketing, he has led worldwide teams to drive product development and commercialization across a number of therapeutic areas, including oncology. Currently, Patrick serves on the Board of Directors of several private and listed companies in the pharmaceutical and biotechnology space, including Santhera Pharmaceuticals, Acacia Pharma, and Spero Therapeutics. He is a Dutch citizen and resides in Switzerland.

Scroll to Top